Compassionate Use

Overview

Expanded Access (known as Compassionate Use) allows for patients who meet certain requirements to receive drugs that have not yet been approved and that are still undergoing clinical development.

Explore Tags

Myeloma Treatments

The following is a listing of myeloma treatments associated with this tag.

All Treatments

View all treatments in development for myeloma patients around the US.

Verified GSK2857916
GSK2857916

GSK2857916 is an antibody-drug conjugate (ADC) directed against the B-cell maturation antigen (BCMA).

Verified Selinexor
Selinexor

Selinexor belongs to a class of drug called selective inhibitor of nuclear export (SINE) and works by disrupting survival mechanisms in myeloma cells.

SparkCures Verified Accurate, up-to-date information. Learn more

Early Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified GSK2857916
GSK2857916

GSK2857916 is an antibody-drug conjugate (ADC) directed against the B-cell maturation antigen (BCMA).

Verified Selinexor
Selinexor

Selinexor belongs to a class of drug called selective inhibitor of nuclear export (SINE) and works by disrupting survival mechanisms in myeloma cells.

SparkCures Verified Accurate, up-to-date information. Learn more

Late Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified GSK2857916
GSK2857916

GSK2857916 is an antibody-drug conjugate (ADC) directed against the B-cell maturation antigen (BCMA).

Verified Selinexor
Selinexor

Selinexor belongs to a class of drug called selective inhibitor of nuclear export (SINE) and works by disrupting survival mechanisms in myeloma cells.

SparkCures Verified Accurate, up-to-date information. Learn more

Myeloma Clinical Trials

The following is a listing of myeloma clinical trials associated with this tag.

All Clinical Trials

View all active clinical trials around the US.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources